ALX Oncology Holdings Inc. appoints Jeanne Jew as Chief Business Officer in August 2020. Ms. Jew brings to ALX Oncology over 25 years of business development and commercial planning experience in the biopharmaceutical industry, most recently serving as Senior Vice President of Business Development of Paratek Pharmaceuticals.